Joanne F. Liutkus Medicine Professional Corporation

Cambridge, Ontario N3H 4L5

0 studies enrolling now · 7 studies all time

What they study most

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Dyslipidemia, Obesity, Severe Hypertriglyceridemia, Type 2 Diabetes Mellitus, Type2 Diabetes

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before — Completed
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight — Completed
• A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants — Completed
• A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone — Completed